Literature DB >> 11918686

Diversity in MHC class II antigen presentation.

John H Robinson1, Alexei A Delvig.   

Abstract

Processing exogenous and endogenous proteins for presentation by major histocompatibility complex (MHC) molecules to T cells is the defining function of antigen-presenting cells (APC) as major regulatory cells in the acquired immune response. MHC class II-restricted antigen presentation to CD4 T cells is achieved by an essentially common pathway that is subject to variation with regard to the location and extent of degradation of protein antigens and the site of peptide binding to MHC class II molecules. These subtle variations reveal a surprising flexibility in the ways a diverse peptide repertoire is displayed on the APC surface. This diversity may have profound consequences for the induction of immunity to infection and tumours, as well as autoimmunity and tolerance.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11918686      PMCID: PMC1782669          DOI: 10.1046/j.0019-2805.2001.01358.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  123 in total

Review 1.  Antigen processing and presentation--towards the millennium.

Authors:  G J Hämmerling; A B Vogt; H Kropshofer
Journal:  Immunol Rev       Date:  1999-12       Impact factor: 12.988

2.  Extracellular antigen processing and presentation by immature dendritic cells.

Authors:  L Santambrogio; A K Sato; G J Carven; S L Belyanskaya; J L Strominger; L J Stern
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

Review 3.  Quality control of MHC class II associated peptides by HLA-DM/H2-M.

Authors:  A B Vogt; S O Arndt; G J Hämmerling; H Kropshofer
Journal:  Semin Immunol       Date:  1999-12       Impact factor: 11.130

4.  HLA-DR-restricted presentation of purified myelin basic protein is independent of intracellular processing.

Authors:  M Vergelli; V Pinet; A B Vogt; M Kalbus; M Malnati; P Riccio; E O Long; R Martin
Journal:  Eur J Immunol       Date:  1997-04       Impact factor: 5.532

5.  Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus.

Authors:  T Nakagawa; W Roth; P Wong; A Nelson; A Farr; J Deussing; J A Villadangos; H Ploegh; C Peters; A Y Rudensky
Journal:  Science       Date:  1998-04-17       Impact factor: 47.728

Review 6.  Capture and processing of exogenous antigens for presentation on MHC molecules.

Authors:  C Watts
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

7.  Major histocompatibility complex class II-transfected tumor cells present endogenous antigen and are potent inducers of tumor-specific immunity.

Authors:  T D Armstrong; V K Clements; B K Martin; J P Ting; S Ostrand-Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-24       Impact factor: 11.205

8.  Distinct accessory cell requirements define two types of rat T cell hybridomas specific for unique determinants in the encephalitogenic 68-86 region of myelin basic protein.

Authors:  M D Mannie; P Y Paterson; D W Thomas; R Nairn
Journal:  J Immunol       Date:  1990-01-15       Impact factor: 5.422

Review 9.  Human tumor antigens: implications for cancer vaccine development.

Authors:  R F Wang
Journal:  J Mol Med (Berl)       Date:  1999-09       Impact factor: 4.599

10.  Cancer immunotherapy by antisense suppression of Ii protein in MHC-class-II-positive tumor cells.

Authors:  G Qiu; J Goodchild; R E Humphreys; M Xu
Journal:  Cancer Immunol Immunother       Date:  1999-12       Impact factor: 6.968

View more
  34 in total

1.  Presentation of the candidate rheumatoid arthritis autoantigen aggrecan by antigen-specific B cells induces enhanced CD4(+) T helper type 1 subset differentiation.

Authors:  Caroline L Wilson; Dominic W Hine; Ariel Pradipta; Jeffrey P Pearson; Willem van Eden; John H Robinson; Andrew M Knight
Journal:  Immunology       Date:  2012-04       Impact factor: 7.397

2.  Major histocompatibility class II molecules prevent destructive processing of exogenous peptides at the cell surface of macrophages for presentation to CD4 T cells.

Authors:  Alexei von Delwig; Julie A Musson; Joe Gray; Norman McKie; John H Robinson
Journal:  Immunology       Date:  2005-02       Impact factor: 7.397

3.  The immune function of MHC class II molecules mutated in the putative superdimer interface.

Authors:  John D Hayball; Richard A Lake
Journal:  Mol Cell Biochem       Date:  2005-05       Impact factor: 3.396

4.  Mechanisms of major histocompatibility complex class II-restricted processing and presentation of the V antigen of Yersinia pestis.

Authors:  Ho-Ki Shim; Julie A Musson; Helen M Harper; Hesta V McNeill; Nicola Walker; Helen Flick-Smith; Alexei von Delwig; E Diane Williamson; John H Robinson
Journal:  Immunology       Date:  2006-08-18       Impact factor: 7.397

5.  Functional expression of chemokine receptor CCR5 on CD4(+) T cells during virus-induced central nervous system disease.

Authors:  William G Glass; Thomas E Lane
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

6.  TRIF-GEFH1-RhoB pathway is involved in MHCII expression on dendritic cells that is critical for CD4 T-cell activation.

Authors:  Hokuto Kamon; Takaya Kawabe; Hidemitsu Kitamura; Jihye Lee; Daisuke Kamimura; Tsuneyasu Kaisho; Shizuo Akira; Akihiro Iwamatsu; Hisashi Koga; Masaaki Murakami; Toshio Hirano
Journal:  EMBO J       Date:  2006-08-17       Impact factor: 11.598

7.  Therapeutic effects of CSF1R-blocking antibodies in multiple myeloma.

Authors:  Q Wang; Y Lu; R Li; Y Jiang; Y Zheng; J Qian; E Bi; C Zheng; J Hou; S Wang; Q Yi
Journal:  Leukemia       Date:  2017-06-19       Impact factor: 11.528

Review 8.  Mycobacterium tuberculosis-specific CD8+ T cells and their role in immunity.

Authors:  Joshua S M Woodworth; Samuel M Behar
Journal:  Crit Rev Immunol       Date:  2006       Impact factor: 2.214

Review 9.  Epigenetic Changes During Food-Specific Immunotherapy.

Authors:  Bryan J Bunning; Rosemarie H DeKruyff; Kari C Nadeau
Journal:  Curr Allergy Asthma Rep       Date:  2016-11       Impact factor: 4.806

10.  On the biological relevance of MHC class II and B7 expression by tumour cells in melanoma metastases.

Authors:  M R Bernsen; L Håkansson; B Gustafsson; L Krysander; B Rettrup; D Ruiter; A Håkansson
Journal:  Br J Cancer       Date:  2003-02-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.